Due to its significant role in cancer, PRC1 components have potential as diagnostic markers. Elevated levels of BMI1, for example, have been detected in the blood of cancer patients, making it a potential biomarker for early detection. Additionally, the expression patterns of PRC1 components can help in identifying specific cancer subtypes, thereby aiding in personalized treatment strategies.
